Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Daimuron SCHEMBL7587643 | 0.85 | MAPT (0.34) | MAPT | |
| SCHEMBL5467830 | 0.82 | MAPT (0.37) | ALDH1A1MAPTKMT2A | |
| SCHEMBL39177 | 0.82 | MAPT (0.37) | ALDH1A1MAPTKMT2A | |
| Tebutam SCHEMBL7576694 | 0.77 | THRB (0.34) | MEN1ALDH1A1LMNAPOLBKMT2A | |
| SCHEMBL8897906 | 0.77 | ALDH1A1 (0.34) | MEN1ALDH1A1LMNAPLA2G1BPOLB | |
| SCHEMBL8897908 | 0.77 | ALDH1A1 (0.34) | MEN1ALDH1A1LMNAPLA2G1BPOLB | |
| SCHEMBL7580161 | 0.76 | CASP3 (0.32) | MEN1MAPTKMT2A | |
| SCHEMBL8888819 | 0.76 | MAPT (0.33) | ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL8888827 | 0.76 | MAPT (0.33) | ALDH1A1LMNAMAPTKMT2A | |
| Clopyralid SCHEMBL7579092 | 0.76 | KMT2A (0.32) | MEN1ALDH1A1LMNAPLA2G1BPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | CYP3A4 179/4885MEN1 4274/4885ALDH1A1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.